Dear Sir, The effect of chronic hyperglycaemia in glycating body proteins is generally agreed to contribute to the secondary consequences of diabetes mellitus [1, 2] . But it is not widely recognised that even if there is a rapid return to normoglycaemia, the later more damaging stages of the glycation sequence cannot be avoided. In vitro work shows that the initial glucoseprotein adduct formed in the presence of excess glucose, is converted to its more reactive and permanent forms (Amadori product and crosslinked aggregates) by internal molecular rearrangements that do not require free glucose [3, 4] . These later glycation products tend to accumulate on proteins with low turnover. So in vivo, even brief hyperglycaemic episodes could lead to cumulative and irreversible damage, particularly if they occur often. Repeated hyperglycaemic episodes are common in poorly controlled diabetic patients and (see below) in kidney patients undergoing regular dialysis.
Our preliminary data indicate that the later stages of glycation are glucose-independent in viv6 as well as in vitro. Figure 1 shows the conversion of plasma proteins to their Amadori product, in a ketotic diabetic patient returning to normoglycaemia. The most striking point is that Amadori product levels continue to rise as glucose levels fall. This behaviour would be expected from the published rate constants for in vitro glycation [5] but has not to our knowledge been reported for in vivo glycation. This is probably because observations are seldom made in the critical time period i.e. 20-80 h after a glucose challenge. If the Amadori product continues to form after return to normoglycaemia, this could explain why a tendency to even mild hyperglycaemia can double the risk of stroke and coronary heart disease [6] . In this Whitehall study, subjects with 2 h blood glucose levels of 5.4-11.0 mmol/1 (following a 50 g oral glucose intake) came into this risk category. We have found that similar glucose levels can be induced in non-diabetic patients by haemodialysis. We compared preand post-dialysis levels of plasma glucose in a random sample of non-diabetic kidney patients undergoing routine dialysis for 6 h periods. The dialysis fluid was 11.1 mmol/1 (200 g/l) in glucose. Although diabetic patients were rigorously excluded from the analysis on the basis of clinical history and pre-dialysis glucose levels, we found that in 39% of cases, plasma glucose levels rose during dialysis to 7.4 mmol/1 or more (n= 71). In 14% of cases, post-dialysis levels rose to 9.0 mmol/1 or more. There was no correlation between post-dialysis glucose levels and age.
Although this hyperglycaemia is comparatively mild, we may assume that glucose-independent reactions continue after return to normoglycaemia, as shown in Figure 1 . So, frequent hyperglycaemic episodes which occur in patients undergoing regular dialysis, having impaired glucose tolerance or poorly controlled diabetes mellitus would be expected to promote the accumulation of glucose-modified proteins. The meeting will be held from January 28-30, 1990 in Igls, Austria. 
